Compound Evidence File
#EC-2026-0817
Prostamax
Filed under Peptides. The bureau holds 196 laboratory returns for this compound from 88 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
88 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| HomopeptideCASE #VI-2026-0760 | A | 7 | 10.0 | 9.9 | 10.0 | 21 May 2026 | 21 May 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 5 | 10.0 | 9.9 | 10.0 | 23 Dec 2025 | 8 Jul 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 4 | 10.0 | 10.0 | 10.0 | 14 Jan 2026 | 13 Jun 2026 |
| Hybio PharmaceuticalCASE #VI-2026-0065 | A | 4 | 10.0 | 9.9 | 10.0 | 11 Dec 2025 | 12 Jul 2026 |
| AmbioPharmCASE #VI-2026-0177 | A | 4 | 10.0 | 10.0 | 10.0 | 21 May 2026 | 5 Aug 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 3 | 10.0 | 9.9 | 10.0 | 11 Apr 2026 | 22 May 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 3 | 10.0 | 9.9 | 10.0 | 3 May 2026 | 20 Jun 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 2 | 10.0 | 10.0 | 10.0 | 16 Apr 2026 | 26 Apr 2026 |
| GenScript PeptidesCASE #VI-2026-0860 | A | 2 | 10.0 | 10.0 | 10.0 | 13 May 2026 | 9 Jun 2026 |
| LipeptidesCASE #VI-2026-0863 | X | 1 | 10.0 | 10.0 | 10.0 | 2 Jul 2025 | 2 Jul 2025 |
| Polaris PeptidesCASE #VI-2026-0839 | X | 1 | 10.0 | 10.0 | 10.0 | 2 Jul 2025 | 2 Jul 2025 |
| Lux Synth AminosCASE #VI-2026-0700 | X | 1 | 10.0 | 10.0 | 10.0 | 11 Jun 2025 | 11 Jun 2025 |
| Orbitrex PeptidesCASE #VI-2026-0812 | X | 1 | 10.0 | 10.0 | 10.0 | 27 Feb 2025 | 27 Feb 2025 |
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 5 | 9.9 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 4 | 9.9 | 9.9 | 10.0 | 12 Nov 2025 | 21 May 2026 |
| PolyPeptide GroupCASE #VI-2026-0143 | A | 4 | 9.9 | 9.9 | 10.0 | 7 May 2026 | 20 Jul 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 3 | 9.9 | 9.9 | 10.0 | 16 Feb 2026 | 6 Jun 2026 |
| BachemCASE #VI-2026-0314 | A | 3 | 9.9 | 9.9 | 10.0 | 4 Dec 2025 | 20 Apr 2026 |
| Sigma-AldrichCASE #VI-2026-0829 | A | 3 | 9.9 | 9.9 | 10.0 | 6 Jun 2026 | 19 Aug 2026 |
| Thermo Fisher ScientificCASE #VI-2026-0142 | A | 3 | 9.9 | 9.9 | 9.9 | 13 Jul 2026 | 17 Aug 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 2 | 9.9 | 9.9 | 10.0 | 2 Jul 2026 | 4 Jul 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 2 | 9.9 | 9.9 | 10.0 | 10 Jan 2026 | 21 Jun 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 2 | 9.9 | 9.9 | 10.0 | 28 Mar 2026 | 15 Jun 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 2 | 9.9 | 9.9 | 10.0 | 10 May 2026 | 1 Jun 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 2 | 9.9 | 9.9 | 9.9 | 14 Mar 2026 | 15 May 2026 |
| SinoPepCASE #VI-2026-0387 | A | 2 | 9.9 | 9.9 | 10.0 | 3 Jun 2026 | 11 Jun 2026 |
| AsymchemCASE #VI-2026-0091 | A | 2 | 9.9 | 9.9 | 10.0 | 18 Jun 2026 | 24 Jul 2026 |
| Shanghai Leader Peptide BiotechnologyCASE #VI-2026-0558 | X | 1 | 9.6 | 9.6 | 9.6 | 11 Jun 2025 | 11 Jun 2025 |
| Precision Peptide CoCASE #VI-2026-0559 | X | 1 | 9.4 | 9.4 | 9.4 | 21 May 2025 | 21 May 2025 |
| Hunan GoodPeptides Biotech CoCASE #VI-2026-0370 | X | 1 | 9.3 | 9.3 | 9.3 | 11 Jun 2025 | 11 Jun 2025 |
| Prime PeptidesCASE #VI-2026-0696 | X | 1 | 9.2 | 9.2 | 9.2 | 21 May 2025 | 21 May 2025 |
| Kerisite Shenzhen InternationalCASE #VI-2026-0315 | X | 1 | 9.0 | 9.0 | 9.0 | 24 Apr 2025 | 24 Apr 2025 |
| HazelCASE #VI-2026-0392 | X | 1 | 8.9 | 8.9 | 8.9 | 24 Apr 2025 | 24 Apr 2025 |
| NUPEPS PeptidesCASE #VI-2026-0896 | X | 1 | 8.8 | 8.8 | 8.8 | 13 Feb 2025 | 13 Feb 2025 |
| Aavant ResearchCASE #VI-2026-0831 | X | 1 | 8.8 | 8.8 | 8.8 | 17 Dec 2024 | 17 Dec 2024 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 2 | 8.6 | 7.7 | 9.4 | 24 May 2026 | 24 May 2026 |
| Nuscience PeptidesCASE #VI-2026-0554 | X | 2 | 8.6 | 7.6 | 9.7 | 28 Mar 2025 | 24 May 2026 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 5 | 8.5 | 7.3 | 10.0 | 25 May 2026 | 25 May 2026 |
| ScienceCASE #VI-2026-0636 | X | 1 | 8.5 | 8.5 | 8.5 | 9 Jun 2025 | 9 Jun 2025 |
| TCICASE #VI-2026-0650 | X | 1 | 8.3 | 8.3 | 8.3 | 3 Jun 2025 | 3 Jun 2025 |
| Bulk Peptide SupplyCASE #VI-2026-0446 | X | 1 | 8.2 | 8.2 | 8.2 | 13 Feb 2025 | 13 Feb 2025 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 4 | 8.1 | 6.8 | 9.7 | 24 May 2026 | 24 May 2026 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 4 | 8.1 | 7.5 | 9.3 | 24 May 2026 | 24 May 2026 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 4 | 8.1 | 7.9 | 8.4 | 21 May 2026 | 21 May 2026 |
| Rayshine Peptide BiochemicalsCASE #VI-2026-0545 | X | 1 | 8.0 | 8.0 | 8.0 | 13 Jun 2025 | 13 Jun 2025 |
| Bio PepzCASE #VI-2026-0436 | X | 1 | 8.0 | 8.0 | 8.0 | 9 Jun 2025 | 9 Jun 2025 |
| Huayi BiotechnologyCASE #VI-2026-0243 | X | 1 | 7.9 | 7.9 | 7.9 | 16 Mar 2025 | 16 Mar 2025 |
| Heman Peptide HMCASE #VI-2026-0089 | X | 1 | 7.9 | 7.9 | 7.9 | 14 Jan 2025 | 14 Jan 2025 |
| Peptide-SCASE #VI-2026-0111 | X | 3 | 7.8 | 7.6 | 8.1 | 13 Feb 2025 | 26 Jan 2026 |
| Zenith Jove Peptide ZJCASE #VI-2026-0570 | X | 1 | 7.8 | 7.8 | 7.8 | 11 Jun 2025 | 11 Jun 2025 |
| LiliPeptideCASE #VI-2026-0695 | X | 12 | 7.5 | 4.4 | 10.0 | 3 Jun 2025 | 23 May 2026 |
| Reta-PeptideCASE #VI-2026-0756 | X | 3 | 7.5 | 7.1 | 8.1 | 16 Mar 2025 | 21 May 2026 |
| Eternal PeptidesCASE #VI-2026-0842 | X | 2 | 7.5 | 4.9 | 10.0 | 7 May 2025 | 24 May 2026 |
| Shanghai Wibson Biotechnology WBSCASE #VI-2026-0214 | X | 1 | 7.5 | 7.5 | 7.5 | 6 May 2025 | 6 May 2025 |
| ZLZ PeptideCASE #VI-2026-0524 | X | 7 | 7.4 | 6.1 | 8.3 | 8 Jul 2025 | 17 May 2026 |
| Evolve BioPepCASE #VI-2026-0755 | X | 1 | 7.4 | 7.4 | 7.4 | 28 Mar 2025 | 28 Mar 2025 |
| HK PeptidesCASE #VI-2026-0140 | X | 5 | 7.1 | 5.0 | 9.3 | 25 Apr 2025 | 19 Jan 2026 |
| YB PeptideCASE #VI-2026-0813 | X | 1 | 6.9 | 6.9 | 6.9 | 17 Dec 2024 | 17 Dec 2024 |
| Shenzhen Jiechuang TradingCASE #VI-2026-0292 | X | 1 | 6.9 | 6.9 | 6.9 | 25 Apr 2025 | 25 Apr 2025 |
| Atomik LabzCASE #VI-2026-0327 | X | 4 | 6.8 | 6.2 | 7.6 | 13 Feb 2025 | 20 May 2026 |
| OupeptideCASE #VI-2026-0435 | X | 6 | 6.6 | 4.9 | 8.8 | 25 Apr 2025 | 23 May 2026 |
| Nanjing Xiyuxun Technology XYXCASE #VI-2026-0433 | X | 1 | 6.6 | 6.6 | 6.6 | 27 Feb 2025 | 27 Feb 2025 |
| Laicuinuo LCNCASE #VI-2026-0223 | X | 1 | 6.1 | 6.1 | 6.1 | 11 Jun 2025 | 11 Jun 2025 |
| Yongkang Nuoao Trading CoCASE #VI-2026-0646 | X | 1 | 6.1 | 6.1 | 6.1 | 13 Jun 2025 | 13 Jun 2025 |
| Xian Yihang TechnologyCASE #VI-2026-0656 | X | 3 | 5.8 | 3.5 | 7.5 | 16 Mar 2025 | 17 May 2026 |
| Alpha-GenCASE #VI-2026-0905 | X | 2 | 5.8 | 5.2 | 6.3 | 14 Jan 2025 | 17 May 2026 |
| SRY LabsCASE #VI-2026-0657 | X | 2 | 5.6 | 5.2 | 6.0 | 9 Jun 2025 | 20 May 2026 |
| Coastal PeptidesCASE #VI-2026-0958 | X | 2 | 5.3 | 5.1 | 5.6 | 8 Jul 2025 | 21 May 2026 |
| Qingdao Hongshengda TradingCASE #VI-2026-0334 | X | 1 | 5.3 | 5.3 | 5.3 | 13 Feb 2025 | 13 Feb 2025 |
| Amino AsylumCASE #VI-2026-0828 | X | 1 | 5.2 | 5.2 | 5.2 | 3 Jul 2025 | 3 Jul 2025 |
| Amino AmigosCASE #VI-2026-0061 | X | 3 | 5.1 | 4.6 | 5.7 | 25 Apr 2025 | 25 May 2026 |
| CellupepCASE #VI-2026-0888 | X | 1 | 5.1 | 5.1 | 5.1 | 3 Jul 2025 | 3 Jul 2025 |
| Richards Biotech Simply RichardsCASE #VI-2026-0307 | X | 1 | 5.0 | 5.0 | 5.0 | 14 Jan 2025 | 14 Jan 2025 |
| Wolverine PeptidesCASE #VI-2026-0262 | X | 1 | 4.9 | 4.9 | 4.9 | 24 Apr 2025 | 24 Apr 2025 |
| Peptide CraftersCASE #VI-2026-0994 | X | 2 | 4.8 | 4.4 | 5.2 | 13 Feb 2025 | 21 May 2026 |
| Suaway Lab ResearchCASE #VI-2026-0488 | X | 2 | 4.8 | 3.8 | 5.9 | 17 Dec 2024 | 21 May 2026 |
| Liberty PeptidesCASE #VI-2026-0416 | X | 1 | 4.5 | 4.5 | 4.5 | 11 Jun 2025 | 11 Jun 2025 |
| Amplified AminoCASE #VI-2026-0748 | X | 1 | 3.9 | 3.9 | 3.9 | 13 Jun 2025 | 13 Jun 2025 |
| Regenerative ResearchCASE #VI-2026-0349 | X | 1 | 3.8 | 3.8 | 3.8 | 3 Jun 2025 | 3 Jun 2025 |
| Wuhan Newtop BiotechCASE #VI-2026-0676 | X | 1 | 3.1 | 3.1 | 3.1 | 14 Jan 2025 | 14 Jan 2025 |
| Peptides For SaleCASE #VI-2026-0614 | X | 1 | 2.2 | 2.2 | 2.2 | 2 Apr 2025 | 2 Apr 2025 |
| PepLab SolutionsCASE #VI-2026-0431 | X | 1 | 1.4 | 1.4 | 1.4 | 2 Jul 2025 | 2 Jul 2025 |
| Guangzhou Yuao TradingCASE #VI-2026-0787 | X | 1 | 0.1 | 0.1 | 0.1 | 7 May 2025 | 7 May 2025 |
| NuLife PeptidesCASE #VI-2026-0980 | X | 1 | 0.0 | 0.0 | 0.0 | 28 Mar 2025 | 28 Mar 2025 |
| PRIVATECASE #VI-2026-0635 | X | 1 | 0.0 | 0.0 | 0.0 | 2 Apr 2025 | 2 Apr 2025 |
| Hebei Chengtong TechnologyCASE #VI-2026-0520 | X | 1 | 0.0 | 0.0 | 0.0 | 11 Jun 2025 | 11 Jun 2025 |
| Zhuoyue BiotechnologyCASE #VI-2026-0632 | X | 1 | 0.0 | 0.0 | 0.0 | 9 Jun 2025 | 9 Jun 2025 |
| SubQ SocietyCASE #VI-2026-0716 | X | 1 | 0.0 | 0.0 | 0.0 | 16 Mar 2025 | 16 Mar 2025 |
Open any subject to view the batch-level evidence for Prostamax alone.